Symmetry Investments’s Teladoc Health TDOC Stock Holding History

Symmetry Investments’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,000	Closed	-$87.1K	–	186
2025 Q2	$87.1K	Buy	+10,000	New	+$72.5K	0.01%	122

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Symmetry Investments's TDOC Position: Q1 2023 in Review

Symmetry Investments sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 27,721 shares — an estimated $656K sold.

Symmetry Investments first reported a position in TDOC in Q4 2022 and held it in 1 quarter. The position peaked at $656K in Q4 2022. 430 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

Symmetry Investments reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
Symmetry Investments sold 27,721 Teladoc Health shares in Q1 2023, an estimated $656K.
Symmetry Investments first reported a position in Teladoc Health in Q4 2022 and held it in 1 quarter.
Symmetry Investments's Teladoc Health position peaked at $656K in Q4 2022.
430 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Symmetry Investments's 13F filing for Q1 2023, filed 15 May 2023.